A pharmaceutical company faces a price regulation where it cannot charge any higher than $5,000 for a lifesaving drug. The company knows that the patients put a high value on this product and are willing to pay up to $10,000 for it. The company decides
to sell the drug at $5,000 and receives another $5,000 from administration through their exclusive medical service providers. This is an example of
a. Tying
b. Bundling
c. Exclusion
d. Fraud, the company is not allowed to sell for any higher than the regulatory price
Answer: c
Economics
You might also like to view...
From the table above, which gives data about the U.S. labor market in 1933, the labor force is
A) 48 million. B) 60 million. C) 65 million. D) 100 million. E) 12 million.
Economics
Missy recently rearranged her portfolio so that it has a higher average return. As a result of this rearranging, Missy
a. raised both firm-specific risk and market risk. b. raised firm-specific risk, but not market risk. c. raised market risk, but not firm-specific risk. d. None of the above is correct.
Economics